Neuland Laboratories Q1 revenue falls 32% to INR 301cr

Neuland Laboratories Limited reported total income of INR 300.6 crores for Q1 FY26, down 32.4% from INR 444 crores in the same period last year.

Profit after tax plummeted to INR 13.7 crores from INR 98.3 crores in Q1 FY25, with quarterly EPS of INR 10.7 per share.

The company attributed weak performance to the uneven nature of its CDMO and specialty GDS businesses. Management expects growth to resume in the latter half of FY26, supported by commercialization of its Unit 3 production block.

CAPEX for FY26 is projected at INR 250 crores.